Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy

Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy

US Patent 9822347 · Granted Nov 21, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Fusion proteins comprising an engineered knottin peptide and uses thereof2025
Methods of engineering transferrin receptor binding polypeptides2024
Soluble leukemia inhibitory factor receptor polypeptides and methods of using sa2024
Methods and systems for screening using microcapillary arrays2024
Methods of engineering transferrin receptor binding polypeptides2024
Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods t2024
Fusion proteins comprising enzyme replacement therapy enzymes2024
Engineered transferrin receptor binding polypeptides2023
Engineered polypeptides2023